NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Major Depressive Disorder
In brief
The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.
Key facts
- Study ID
- NCT06963021
- Run by
- Neurocrine Biosciences
- People needed
- 200
- Starts
- 2025-05-30
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-06-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Neurocrine Clinical Site — Southampton, United Kingdom (enrolling)
- Neurocrine Clinical Site — Los Angeles, California, United States (enrolling)
- Neurocrine Clinical Site — Stanford, California, United States (enrolling)
- Neurocrine Clinical Site — Aurora, Colorado, United States (enrolling)
- Neurocrine Clinical Site — Jelgava, Latvia (enrolling)
- Neurocrine Clinical Site — Liepāja, Latvia (enrolling)
- Neurocrine Clinical Site — Sigulda, Latvia (enrolling)
- Neurocrine Clinical Site — London, United Kingdom (enrolling)
- Neurocrine Clinical Site — Salford, United Kingdom (enrolling)
- Neurocrine Clinical Site — Sheffield, United Kingdom (enrolling)
- Neurocrine Clinical Site — Chino, California, United States (enrolling)
- Neurocrine Clinical Site — Maitland, Florida, United States (enrolling)
- Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
- Neurocrine Clinical Site — Cedarhurst, New York, United States (enrolling)
- Neurocrine Clinical Site — New York, New York, United States (enrolling)
- Neurocrine Clinical Site — Charlotte, North Carolina, United States (enrolling)
- Neurocrine Clinical Site — Philadelphia, Pennsylvania, United States (enrolling)
- Neurocrine Clinical Site — Bruges, Belgium (enrolling)
- Neurocrine Clinical Site — Mechelen, Belgium (enrolling)
- Neurocrine Clinical Site — Toronto, Ontario, Canada (enrolling)
- Neurocrine Clinical Site — Kuopio, Finland (enrolling)
- Neurocrine Clinical Site — Oulu, Finland (enrolling)
- Neurocrine Clinical Site — Tampere, Finland (enrolling)
- Neurocrine Clinical Site — Budapest, Hungary (enrolling)
- Neurocrine Clinical Site — Budapest, Hungary (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.